Seminars in Nephrology
Volume 28, Issue 3 , Pages 266-278 , May 2008

Bypassing Vasopressin Receptor Signaling Pathways in Nephrogenic Diabetes Insipidus

References 

  1. Deen PM. Mouse models for congenital nephrogenic diabetes insipidus: what can we learn from them?. Nephrol Dial Transplant. 2007;22:1023–1026
  2. Wade JB, Stetson DL, Lewis SA. ADH action: evidence for a membrane shuttle mechanism. Ann NY Acad Sci. 1981;372:107–117
  3. Kamsteeg EJ, Heijnen I, van Os CH, et al. The subcellular localization of an aquaporin-2 tetramer depends on the stoichiometry of phosphorylated and nonphosphorylated monomers. J Cell Biol. 2000;151:919–930
  4. Yip KP. Coupling of vasopressin-induced intracellular Ca2+ mobilization and apical exocytosis in perfused rat kidney collecting duct. J Physiol. 2002;538:891–899
  5. Nickols HH, Shah VN, Chazin WJ, et al. Calmodulin interacts with the V2 vasopressin receptor: elimination of binding to the C terminus also eliminates arginine vasopressin-stimulated elevation of intracellular calcium. J Biol Chem. 2004;279:46969–46980
  6. Robben JH, Knoers NV, Deen PM. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. Am J Physiol Renal Physiol. 2006;291:F257–F270
  7. Morello JP, Salahpour A, Laperriere A, et al. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest. 2000;105:887–895
  8. Schulz A, Sangkuhl K, Lennert T, et al. Aminoglycoside pretreatment partially restores the function of truncated V(2) vasopressin receptors found in patients with nephrogenic diabetes insipidus. J Clin Endocrinol Metab. 2002;87:5247–5257
  9. Deen PTP. Mouse models for congenital nephrogenic diabetes insipidus: what can we learn from them?. Nephrol Dial Transplant. 2007;22:1023–1026
  10. Bichet DG, Ruel N, Arthus MF, et al. Rolipram, a phosphodiesterase inhibitor, in the treatment of two male patients with congenital nephrogenic diabetes insipidus. Nephron. 56:449-50.
  11. Oliveira CJ, Schindler F, Ventura AM, et al. Nitric oxide and cGMP activate the Ras-MAP kinase pathway-stimulating protein tyrosine phosphorylation in rabbit aortic endothelial cells. Free Radic Biol Med. 2003;35:381–396
  12. Yamada T, Matsuda K, Uchiyama M. Atrial natriuretic peptide and cGMP activate sodium transport through PKA-dependent pathway in the urinary bladder of the Japanese tree frog. J Comp Physiol [B]. 2006;176:203–212
  13. Anthony TL, Brooks HL, Boassa D, et al. Cloned human aquaporin-1 is a cyclic GMP-gated ion channel. Mol Pharmacol. 2000;57:576–588
  14. Das S, Garepapaghi M, Palmer LG. Stimulation by cGMP of apical Na channels and cation channels in toad urinary bladder. Am J Physiol Cell Physiol. 1991;260:C234–C241
  15. Etgen GJ, Fryburg DA, Gibbs EM. Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway. Diabetes. 1997;46:1915–1919
  16. Ishikawa Y, Iida H, Ishida H. The muscarinic acetylcholine receptor-stimulated increase in aquaporin-5 levels in the apical plasma membrane in rat parotid acinar cells is coupled with activation of nitric oxide/cGMP signal transduction. Mol Pharmacol. 2002;61:1423–1434
  17. Garcia NH, Stoos BA, Carretero OA, et al. Mechanism of the nitric oxide-induced blockade of collecting duct water permeability. Hypertension. 1996;27:679–683
  18. Hirsch JR, Cermak R, Forssmann WG, et al. Effects of sodium nitroprusside in the rat cortical collecting duct are independent of the NO pathway. Kidney Int. 1997;51:473–476
  19. Ortiz PA, Garvin JL. Role of nitric oxide in the regulation of nephron transport. Am J Physiol Renal Physiol. 2002;282:F777–F784
  20. Martin PY, Bianchi M, Roger F, et al. Arginine vasopressin modulates expression of neuronal NOS in rat renal medulla. Am J Physiol Renal Physiol. 2002;283:F559–F568
  21. Shin SJ, Lai FJ, Wen JD, et al. Increased nitric oxide synthase mRNA expression in the renal medulla of water-deprived rats. Kidney Int. 1999;56:2191–2202
  22. Morishita T, Tsutsui M, Shimokawa H, et al. Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms. Proc Natl Acad Sci U S A. 2005;102:10616–10621
  23. Pilz RB, Casteel DE. Regulation of gene expression by cyclic GMP. Circ Res. 2003;93:1034–1046
  24. Bouley R, Breton S, Sun T, et al. Nitric oxide and atrial natriuretic factor stimulate cGMP-dependent membrane insertion of aquaporin 2 in renal epithelial cells. J Clin Invest. 2000;106:1115–1126
  25. Wang W, Li C, Nejsum LN, et al. Biphasic effects of ANP infusion in conscious, euvolumic rats: roles of AQP2 and ENaC trafficking. Am J Physiol Renal Physiol. 2006;290:F530–F541
  26. Bouley R, Pastor-Soler N, Cohen O, et al. Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra). Am J Physiol Renal Physiol. 2005;288:F1103–F1112
  27. Brodsky FM, Chen CY, Knuehl C, et al. Biological basket weaving: formation and function of clathrin-coated vesicles. Annu Rev Cell Dev Biol. 2001;17:517–568
  28. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature. 2003;422:37–44
  29. Brown D, Orci L. Vasopressin stimulates formation of coated pits in rat kidney collecting ducts. Nature. 1983;302:253–255
  30. Sun TX, Van Hoek A, Huang Y, et al. Aquaporin-2 localization in clathrin-coated pits: inhibition of endocytosis by dominant-negative dynamin. Am J Physiol Renal Physiol. 2002;282:F998–F1011
  31. Lu HA, Sun TX, Matsuzaki T, et al. Heat shock protein 70 interacts with aquaporin-2 and regulates its trafficking. J Biol Chem. 2007;282:28721–28732
  32. Kamsteeg EJ, Duffield AS, Konings IB, et al. MAL decreases the internalization of the aquaporin-2 water channel. Proc Natl Acad Sci U S A. 2007;104:16696–16701
  33. Nejsum LN, Zelenina M, Aperia A, et al. Bidirectional regulation of AQP2 trafficking and recycling: involvement of AQP2-S256 phosphorylation. Am J Physiol Renal Physiol. 2005;288:F930–F938
  34. Procino G, Carmosino M, Marin O, et al. Ser-256 phosphorylation dynamics of aquaporin 2 during maturation from the ER to the vesicular compartment in renal cells. FASEB J. 2003;17:1886–1888
  35. Lu H, Sun TX, Bouley R, et al. Inhibition of endocytosis causes phosphorylation (S256)-independent plasma membrane accumulation of AQP2. Am J Physiol Renal Physiol. 2004;286:F233–F243
  36. Russo LM, McKee M, Brown D. Methyl-beta-cyclodextrin induces vasopressin-independent apical accumulation of aquaporin-2 in the isolated, perfused rat kidney. Am J Physiol Renal Physiol. 2006;291:F246–F253
  37. Christensen BM, Zelenina M, Aperia A, et al. Localization and regulation of PKA-phosphorylated AQP2 in response to V(2)-receptor agonist/antagonist treatment. Am J Physiol Renal Physiol. 2000;278:F29–F42
  38. Bouley R, Hawthorn G, Russo LM, et al. Aquaporin 2 (AQP2) and vasopressin type 2 receptor (V2R) endocytosis in kidney epithelial cells: AQP2 is located in ‘endocytosis-resistant’ membrane domains after vasopressin treatment. Biol Cell. 2006;98:215–232
  39. Knepper MA, Nielsen S. Kinetic model of water and urea permeability regulation by vasopressin in collecting duct. Am J Physiol Renal Physiol. 1993;265:F214–F224
  40. Fushimi K, Sasaki S, Marumo F. Phosphorylation of serine 256 is required for cAMP-dependent regulatory exocytosis of the aquaporin-2 water channel. J Biol Chem. 1997;272:14800–14804
  41. Katsura T, Gustafson CE, Ausiello DA. Protein kinase A phosphorylation is involved in regulated exocytosis of aquaporin-2 in transfected LLC-PK1 cells. Am J Physiol Renal Physiol. 1997;272:F817–F822
  42. Stefan E, Wiesner B, Baillie GS, et al. Compartmentalization of cAMP-dependent signaling by phosphodiesterase-4D is involved in the regulation of vasopressin-mediated water reabsorption in renal principal cells. J Am Soc Nephrol. 2007;18:199–212
  43. Brown D. The ins and outs of aquaporin-2 trafficking. Am J Physiol Renal Physiol. 2003;284:F893–F901
  44. Tobert JA. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors. Nat Rev Drug Discov. 2003;2:517–526
  45. Sidaway JE, Davidson RG, McTaggart F, et al. Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase reduce receptor-mediated endocytosis in opossum kidney cells. J Am Soc Nephrol. 2004;15:2258–2265
  46. Verhulst A, D'Haese PC, De Broe ME. Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells. J Am Soc Nephrol. 2004;15:2249–2257
  47. McFarlane SI, Muniyappa R, Francisco R, et al. Clinical review 145: pleiotropic effects of statins: lipid reduction and beyond. J Clin Endocrinol Metab. 2002;87:1451–1458
  48. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int. 2001;59:260–269
  49. Kureishi Y, Luo Z, Shiojima I, et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med. 2000;6:1004–1010
  50. Urbich C, Dernbach E, Zeiher AM, et al. Double-edged role of statins in angiogenesis signaling. Circ Res. 2002;90:737–744
  51. Laufs U, La Fata V, Plutzky J, et al. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation. 1998;97:1129–1135
  52. Park HJ, Kong D, Iruela-Arispe L, et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Circ Res. 2002;91:143–150
  53. Tamma G, Klussmann E, Maric K, et al. Rho inhibits cAMP-induced translocation of aquaporin-2 into the apical membrane of renal cells. Am J Physiol Renal Physiol. 2001;281:F1092–F1101
  54. Klussmann E, Maric K, Wiesner B, et al. Protein kinase A anchoring proteins are required for vasopressin-mediated translocation of aquaporin-2 into cell membranes of renal principal cells. J Biol Chem. 1999;274:4934–4938
  55. Klussmann E, Tamma G, Lorenz D, et al. An inhibitory role of Rho in the vasopressin-mediated translocation of aquaporin-2 into cell membranes of renal principal cells. J Biol Chem. 2001;276:20451–20457
  56. Tamma G, Klussmann E, Procino G, et al. cAMP-induced AQP2 translocation is associated with RhoA inhibition through RhoA phosphorylation and interaction with RhoGDI. J Cell Sci. 2003;116:1519–1525
  57. Noda Y, Sasaki S. Regulation of aquaporin-2 trafficking and its binding protein complex. Biochim Biophys Acta. 2006;1758:1117–1125
  58. Cox RA, Kanagalingam K. A spectrophotometric study of the denaturation of deoxyribonucleic acid in the presence of urea or formaldehyde and its relevance to the secondary structure of single-stranded polynucleotides. Biochem J. 1968;108:599–610
  59. Kotnik P, Nielsen J, Kwon TH, et al. Altered expression of COX-1, COX-2, and mPGES in rats with nephrogenic and central diabetes insipidus. Am J Physiol Renal Physiol. 2005;288:F1053–F1068
  60. Rao R, Zhang MZ, Zhao M, et al. Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria. Am J Physiol Renal Physiol. 2005;288:F642–F649
  61. Pattaragarn A, Alon US. Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor. Pediatr Nephrol. 2003;18:1073–1076
  62. Johnsen SP, Larsson H, Tarone RE, et al. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Arch Intern Med. 2005;165:978–984
  63. Samuelsson B, Morgenstern R, Jakobsson PJ. Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev. 2007;59:207–224
  64. Takeuchi K, Takahashi N, Abe T, et al. Two isoforms of the rat kidney EP3 receptor derived by alternative RNA splicing: intrarenal expression co-localization. Biochem Biophys Res Commun. 1994;199:834–840
  65. Makino H, Tanaka I, Mukoyama M, et al. Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist. J Am Soc Nephrol. 2002;13:1757–1765
  66. Tamma G, Carmosino M, Svelto M, et al. Bradykinin signaling counteracts cAMP-elicited aquaporin 2 translocation in renal cells. J Am Soc Nephrol. 2005;16:2881–2889
  67. Leeb-Lundberg LM, Marceau F, Muller-Esterl W, et al. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev. 2005;57:27–77
  68. Fukuhara S, Sakurai A, Sano H, et al. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol. 2005;25:136–146
  69. Procino G, Carmosino M, Tamma G, et al. Extracellular calcium antagonizes forskolin-induced aquaporin 2 trafficking in collecting duct cells. Kidney Int. 2004;66:2245–2255
  70. Li Y, Shaw S, Kamsteeg EJ, et al. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity. J Am Soc Nephrol. 2006;17:1063–1072
  71. Norregaard R, Jensen BL, Li C, et al. COX-2 inhibition prevents downregulation of key renal water and sodium transport proteins in response to bilateral ureteral obstruction. Am J Physiol Renal Physiol. 2005;289:F322–F333
  72. Fushimi K, Uchida S, Hara Y, et al. Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature. 1993;361:549–552
  73. Nielsen S, DiGiovanni SR, Christensen EI, et al. Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney. Proc Natl Acad Sci U S A. 1993;90:11663–11667
  74. Yasui M, Zelenin SM, Celsi G, et al. Adenylate cyclase-coupled vasopressin receptor activates AQP2 promoter via a dual effect on CRE and AP1 elements. Am J Physiol Renal Physiol. 1997;272:F443–F450
  75. Hozawa S, Holtzman EJ, Ausiello DA. cAMP motifs regulating transcription in the aquaporin-2 gene. Am J Physiol Cell Physiol. 1996;270:C1695–C1702
  76. Frokiaer J, Marples D, Valtin H, et al. Low aquaporin-2 levels in polyuric DI +/+ severe mice with constitutively high cAMP-phosphodiesterase activity. Am J Physiol Renal Physiol. 1999;276:F179–F190
  77. Hasler U, Jeon US, Kim JA, et al. Tonicity-responsive enhancer binding protein is an essential regulator of aquaporin-2 expression in renal collecting duct principal cells. J Am Soc Nephrol. 2006;17:1521–1531
  78. Li SZ, McDill BW, Kovach PA, et al. Calcineurin-NFATc signaling pathway regulates AQP2 expression in response to calcium signals and osmotic stress. Am J Physiol Cell Physiol. 2007;292:C1606–C1616
  79. Hasler U, Mordasini D, Bens M, et al. Long term regulation of aquaporin-2 expression in vasopressin-responsive renal collecting duct principal cells. J Biol Chem. 2002;277:10379–10386
  80. Hasler U, Nielsen S, Feraille E, et al. Posttranscriptional control of aquaporin-2 abundance by vasopressin in renal collecting duct principal cells. Am J Physiol Renal Physiol. 2006;290:F177–F187
  81. Puliyanda DP, Ward DT, Baum MA, et al. Calpain-mediated AQP2 proteolysis in inner medullary collecting duct. Biochem Biophys Res Commun. 2003;303:52–58
  82. Wilke C, Sheriff S, Soleimani M, et al. Vasopressin-independent regulation of collecting duct aquaporin-2 in food deprivation. Kidney Int. 2005;67:201–216
  83. Hasler U, Mordasini D, Bianchi M, et al. Dual influence of aldosterone on AQP2 expression in cultured renal collecting duct principal cells. J Biol Chem. 2003;278:21639–21648

 Supported by National Institutes of Health grant DK38452. Also supported by a Young Investigator Award from the National Kidney Foundation (R.B.), a Swiss Fondation Suisse pour les Bourses en Médicine et Biologie Fellowship and an Executive Committee on Research Fellowship from Massachusetts General Hospital (U.H.), a National Institutes of Health KO8 grant DK075940-01 (H.A.J.L.), and a doctoral level postgraduate scholarship from National Sciences and Engineering Council of Canada (P.N.). The Microscopy Core facility of the MGH Program in Membrane Biology receives additional support from the Boston Area Diabetes and Endocrinology Research Center (DK57521) and the Center for the Study of Inflammatory Bowel Disease (DK43341).

PII: S0270-9295(08)00054-5

doi: 10.1016/j.semnephrol.2008.03.010

Seminars in Nephrology
Volume 28, Issue 3 , Pages 266-278 , May 2008

Article Tools

* Image Usage & Resolution